>Quiz: is the 4th ritonavir or Gilead's own elvitegravir?<
You’re getting warmer: elvitegravir is one of the four drugs in Quadro, but ritonavir is not, and neither is efavirenz.
Hint: The purpose of Quadro is to compete against Atripla; including ritonavir in the mix would cause problems from both a business and a medical standpoint.
Let’s talk biotech! “The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”